Provided by Tiger Trade Technology Pte. Ltd.

Stagezero Life Sciences Ltd.

0.0005
0.0000
Volume:- -
Turnover:- -
Market Cap:61.78K
PE:0.00
High:0.0005
Open:0.0005
Low:0.0005
Close:0.0005
52wk High:0.0727
52wk Low:0.0005
Shares:123.55M
Float Shares:95.52M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1212
EPS(LYR):-0.1148
ROE:-168.85%
ROA:-63.79%
PB:-0.01
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
Stagezero Life Sciences Ltd.
Exchange:
EXPERT
Establishment Date:
- -
Employees:
40
Office Location:
70 East Beaver Creek Road,Unit 30,Richmond Hill,Ontario,Canada
Website:
- -
Zip Code:
L4B 3B2
Phone:
- -
Fax:
- -
Introduction:
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.